Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06287398
Status:
RECRUITING
Last Update Posted:
2024-03-01
First Post:
2024-02-07
Brief Title:
Epcoritamab Epcor-Containing Combination Salvage Therapy Followed by ASCT Epcor Consolidation in Patients With Relapsed LBCL
Sponsor:
Australasian Leukaemia and Lymphoma Group
Organization:
Australasian Leukaemia and Lymphoma Group
Conditions & Keywords Data
Conditions:
| Name |
|---|
| DLBCL - Diffuse Large B Cell Lymphoma |
| High-grade B-cell Lymphoma |
| High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements |
| DLBCL Nos Genetic Subtypes |
| High Grade B-Cell Lymphoma Not Otherwise Specified |
| Follicular Large Cell Lymphoma Relapsed |
| Follicular Large Cell Lymphoma |
Keywords: